banner add

FDA Wants to Oversee Lab Tests It Says Put Patients ‘At Risk’

Genetic testing that reveals potential cancer risks or other maladies with no regulatory oversight is among the targets of the agency’s proposed review.

from NYT > Health https://ift.tt/9Q1CqeD
via IFTTT

No comments

The Organ Transplant List Is Being Ignored

Organ transplant waiting lists are designed to fairly distribute organs to the sickest patients in order of priority. Or so we thought. A Ne...

Theme images by PLAINVIEW. Powered by Blogger.